Breaking News, Promotions & Moves

Alexion Co-founder Retires

O’Neill succeeds Squinto as EVP of global ops

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Stephen Squinto, Ph.D., co-founder and executive vice president, chief global operations officer of Alexion Pharmaceuticals, will retire from the company effective January 1, 2015. Dr. Squinto co-founded Alexion in 1992 with Leonard Bell, M.D., the company’s chairman and chief executive officer.   Dr. Squinto has held numerous leadership positions at Alexion, including executive vice president, head of R&D, leading the development of Soliris (eculizumab) in atypical hemolytic uremic syndrome...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters